Composite pleomorphic xanthoastrocytomaepithelioid glioneuronal tumor with BRAF V600E mutation-report of three cases

Clinical Neuropathology

Volumn 33, Issue 2, 2014, Pages 112-121

  Aisner, Dara L ^a   Newell, Kathy L ^b   Pollack, Ania G ^b   Kleinschmidt DeMasters, Bette K ^a,c   Steinberg, Gary K ^d   Smyth, Lawrence T ^e   Vogel, Hannes ^d  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d STANFORD UNIVERSITY   (United States)

^e KAISER PERMANENTE MEDICAL CENTER   (United States)

Author keywords

BRAF V600E; Composite tumor; Epithelioid; Glioneuronal; Pleomorphic xanthoastrocytoma

Indexed keywords

B RAF KINASE; BRAF PROTEIN, HUMAN; DNA; PROTEIN S 100;

ADOLESCENT; ARTICLE; ASTROCYTOMA; BRAIN HEMORRHAGE; BRAIN TUMOR; ELECTRON MICROSCOPY; EPITHELIOID CELL; FEMALE; GENETICS; GLIOMA; HEADACHE; HUMAN; IMMUNOHISTOCHEMISTRY; MALE; MENTAL DISEASE; METABOLISM; MUTATION; NUCLEAR MAGNETIC RESONANCE IMAGING; PARESIS; PATHOLOGY; POLYMERASE CHAIN REACTION; SPEECH DISORDER; YOUNG ADULT;

ADOLESCENT; ASTROCYTOMA; BRAIN NEOPLASMS; DNA; EPITHELIOID CELLS; FEMALE; GANGLIOGLIOMA; HEADACHE; HUMANS; IMMUNOHISTOCHEMISTRY; INTRACRANIAL HEMORRHAGES; MAGNETIC RESONANCE IMAGING; MALE; MENTAL DISORDERS; MICROSCOPY, ELECTRON; MUTATION; PARESIS; POLYMERASE CHAIN REACTION; PROTO-ONCOGENE PROTEINS B-RAF; S100 PROTEINS; SPEECH DISORDERS; YOUNG ADULT;

EID: 84894380650     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/NP300679     Document Type: Article

References (34)

1. Rosenblum MK, Erlandson RA, Budzilovich GN. The lipid-rich epithelioid glioblastoma. Am J Surg Pathol. 1991; 15: 925-934. CrossRef PubMed
2. Fuller GN, Goodman JC, Vogel H, Ghorbani R. Epithelioid glioblastoma: a distinct clinicopathologic entity. J Neuropathol Exp Neurol. 1998; 57: 501 CrossRef
3. Akimoto J, Namatame H, Haraoka J, Kudo M. Epithelioid glioblastoma: a case report. Brain Tumor Pathol. 2005; 22: 21-27. CrossRef PubMed. .
4. Rodriguez FJ, Scheithauer BW, Giannini C, Bryant SC, Jenkins RB. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study. Cancer. 2008; 113: 2779-2789. CrossRef PubMed.
5. Gasco J, Franklin B, Fuller GN, Salinas P, Prabhu S. Multifocal epithelioid glioblastoma mimicking cerebral metastasis: case report. Neurocirugia (Astur). 2009; 20: 550-554. CrossRef PubMed.
6. Kleinschmidt-DeMasters BK, Alassiri AH, Birks DK, Newell KL, Moore W, Lillehei KO. Epithelioid versus rhabdoid glioblastomas are distinguished by monosomy 22 and immunohistochemical expression of INI-1 but not claudin 6. Am J Surg Pathol. 2010; 34: 341-354. CrossRef PubMed.
7. Tanaka S, Nakada M, Hayashi Y, Nakada S, Sawada-Kitamura S, Furuyama N, Suzuki T, Kamide T, Hayashi Y, Yano S, Hamada J. Epithelioid glioblastoma changed to typical glioblastoma: the methylation status of MGMT promoter and 5-ALA fluorescence. Brain Tumor Pathol. 2011; 28: 59-64. CrossRef PubMed.
8. Burger PC, Yu IT, Tihan T, Friedman HS, Strother DR, Kepner JL, Duffner PK, Kun LE, Perlman EJ. Atypical teratoid/rhabdoid tumor of the central nervous system: a highly malignant tumor of infancy and childhood frequently mistaken for medulloblastoma: a Pediatric Oncology Group study. Am J Surg Pathol. 1998; 22: 1083-1092. CrossRef PubMed.
9. Judkins AR, Burger PC, Hamilton RL, Kleinschmidt- DeMasters B, Perry A, Pomeroy SL, Rosenblum MK, Yachnis AT, Zhou H, Rorke LB, Biegel JA. INI1 protein expression distinguishes atypical teratoid/ rhabdoid tumor from choroid plexus carcinoma. J Neuropathol Exp Neurol. 2005; 64: 391-397. PubMed.
10. Judkins AR, Eberhart CG, Wesseling P. Atypical teratoid/rhabdoid tumour. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds.) WHO Classification of Tumours of the Central Nervous System. Albany, New York: WHO Publications Center; 2007. p. 147-149.
11. Rodriguez FJ, Scheithauer BW, Port JD. Unusual malignant glioneuronal tumors of the cerebrum of adults: a clinicopathologic study of three cases. Acta Neuropathol. 2006; 112: 727-737. CrossRef PubMed.
12. Prayson RA, Chahlavi A. Metastatic epithelioid sarcoma to the brain: palisaded necrosis mimicking glioblastoma multiforme. Ann Diagn Pathol. 2002; 6: 302-306. CrossRef PubMed.
13. Kepes JJ, Fulling KH, Garcia JH. The clinical significance of "adenoid" formations of neoplastic astrocytes, imitating metastatic carcinoma, in gliosarcomas. A review of five cases. Clin Neuropathol. 1982; 1: 139-150. PubMed.
14. Mørk SJ, Rubinstein LJ, Kepes JJ. Patterns of epithelial metaplasia in malignant gliomas. I. Papillary formations mimicking medulloepithelioma. J Neuropathol Exp Neurol. 1988; 47: 93-100. CrossRef PubMed.
15. Mørk SJ, Rubinstein LJ, Kepes JJ, Perentes E, Uphoff DF. Patterns of epithelial metaplasia in malignant gliomas. II. Squamous differentiation of epithelial-like formations in gliosarcomas and glioblastomas. J Neuropathol Exp Neurol. 1988; 47: 101-118. CrossRef PubMed.
16. Ozolek JA, Finkelstein SD, Couce ME. Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature. Mod Pathol. 2004; 17: 739-745. CrossRef PubMed.
17. Kleihues P, Burger PC, Aldape KD et al. Glioblastoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds.). WHO Classification of Tumours of the Central Nervous System. Albany, New York: WHO Publications Center; 2007. p. 33-49.
18. Edgar MA, Rosenblum MK. Mixed glioneuronal tumors: recently described entities. Arch Pathol Lab Med. 2007; 131: 228-233. PubMed.
19. Ozolek JA, Finkelstein SD, Couce ME. Gliosarcoma with epithelial differentiation: immunohistochemical and molecular characterization. A case report and review of the literature. Mod Pathol. 2004; 17: 739-745. CrossRef PubMed.
20. Dias-Santagata D, Lam Q, Vernovsky K, Vena N, Lennerz JK, Borger DR, Batchelor TT, Ligon KL, Iafrate AJ, Ligon AH, Louis DN, Santagata S. BRAF V600E mutations are common in pleomorphic xanthoastrocytoma: diagnostic and therapeutic implications. PLoS ONE. 2011; 6: e17948. CrossRef PubMed.
21. Schindler G, Capper D, Meyer J, Janzarik W, Omran H, Herold-Mende C, Schmieder K, Wesseling P, Mawrin C, Hasselblatt M, Louis DN, Korshunov A, Pfister S, Hartmann C, Paulus W, Reifenberger G, von Deimling A. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extracerebellar pilocytic astrocytoma. Acta Neuropathol. 2011; 121: 397-405. CrossRef PubMed.
22. Allen JC, Judkins AR, Rosenblum MK, Biegel JA. Atypical teratoid/rhabdoid tumor evolving from an optic pathway ganglioglioma: case study. Neuro- oncol. 2006; 8: 79-82. CrossRef PubMed.
23. Kleinschmidt-DeMasters BK, Birks DK, Aisner DL, Hankinson TC, Rosenblum MK. Atypical teratoid/ rhabdoid tumor arising in a ganglioglioma: genetic characterization. Am J Surg Pathol. 2011; 35: 1894-1901. CrossRef PubMed.
24. Chacko G, Chacko AG, Dunham CP, Judkins AR, Biegel JA, Perry A. Atypical teratoid/rhabdoid tumor arising in the setting of a pleomorphic xanthoastrocytoma. J Neurooncol. 2007; 84: 217-222. CrossRef PubMed.
25. Dahse R, Kromeyer-Hauschild K, Berndt A, Kosmehl H. No incidence of BRAF mutations in salivary gland carcinomas-implications for anti- EGFR therapies. J Biomed Biotechnol. 2009; Article ID 501736, 3 pages.
26. Giannini C, Paulus W, Louis DN, Liberski P. Pleomorphic xanthoastrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds). WHO Classification of Tumours of the Central Nervous System. Albany, New York: WHO Publications Center; 2007. p. 22-24.
27. Perry A, Giannini C, Scheithauer BW, Rojiani AM, Yachnis AT, Seo IS, Johnson PC, Kho J, Shapiro S. Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature. Am J Surg Pathol. 1997; 21: 763-771. CrossRef PubMed.
28. Perry A, Scheithauer BW, Szczesniak DM, Atkinson JL, Wald JT, Hammak JE. Combined oligodendroglioma/ pleomorphic xanthoastrocytoma: a probable collision tumor: case report. Neurosurgery. 2001; 48: 1358-1361. PubMed.
29. Sugita Y, Kepes JJ, Shigemori M, Kuramoto S, Reifenberger G, Kiwit JC, Wechsler W. Pleomorphic xanthoastrocytoma with desmoplastic reaction: angiomatous variant. Report of two cases. Clin Neuropathol. 1990; 9: 271-278. PubMed.
30. Ishizawa K, Terao S, Kobayashi K, Yoshida K, Hirose T. A neuroepithelial tumor showing combined histological features of dysembryoplastic neuroepithelial tumor and pleomorphic xanthoastrocytoma - a case report and review of the literature. Clin Neuropathol. 2007; 26: 169-175. Cross- Ref PubMed.
31. Kepes JJ. Pleomorphic xanthoastrocytomas (PXA-s) and lipidized glioblastomas. Brain Tumor Pathol. 1991; 8: 1-4.
32. Iwaki T, Fukui M, Kondo A, Matsushima T, Takeshita I. Epithelial properties of pleomorphic xanthoastrocytomas determined in ultrastructural and immunohistochemical studies. Acta Neuropathol. 1987; 74: 142-150. CrossRef PubMed.
33. Scheithauer BW, Hawkins C, Tihan T, Vanden-Berg SR, Burger PC. Pilomyxoid astrocytoma. In: Louis DN, Ohgaki H, Wiestler OD, Cavenee WK (eds). WHO Classification of Tumours of the Central Nervous System. Albany, New York: WHO Publications Center; 2007. p. 20-21.
34. Kepes JJ, Collins J. Choroid plexus epithelium (normal and neoplastic) expresses synaptophysin. A potentially useful aid in differentiating carcinoma of the choroid plexus from metastatic papillary carcinomas. J Neuropathol Exp Neurol. 1999; 58: 398-401. CrossRef PubMed.